Examination of the Patient and Hospitalization Characteristics of 30-Day SCD Readmissions.
Publication/Presentation Date
9-1-2016
Abstract
OBJECTIVES: Sickle cell disease (SCD) is associated with a high level of emergency department and hospital utilization, as well as a high rate of hospital readmissions. At Johns Hopkins Hospital, as at other institutions, SCD accounts for a large proportion of readmissions. Our study examined patient and hospitalization factors involved in readmissions at Johns Hopkins Hospital.
METHODS: Patients at the Johns Hopkins Sickle Cell Center for Adults with a readmission in fiscal year 2011 were compared with an age- and sex-matched sample of clinic patients for comorbidities, complications, and prior utilization. Hospitalizations that were followed by readmissions were compared with those that were not as to admitting service, length of stay, and average daily opioid dose.
RESULTS: Patients with readmissions had more complications and comorbidities and much higher prior utilization than typical clinic patients, whereas hospitalizations that were followed by readmissions had a longer length of stay but similar opioid doses.
CONCLUSIONS: For patients with SCD with a high volume of hospital use, readmissions may be a natural consequence of a high-admission frequency associated with greater disease severity and higher comorbidity.
Volume
109
Issue
9
First Page
583
Last Page
587
ISSN
1541-8243
Published In/Presented At
Carroll, C. P., Haywood, C., Jr, & Lanzkron, S. M. (2016). Examination of the Patient and Hospitalization Characteristics of 30-Day SCD Readmissions. Southern medical journal, 109(9), 583–587. https://doi.org/10.14423/SMJ.0000000000000526
Disciplines
Business Administration, Management, and Operations | Health and Medical Administration | Management Sciences and Quantitative Methods
PubMedID
27598369
Department(s)
Administration and Leadership
Document Type
Article